Shih-Hsien Hsu

10PUBLICATIONS
8CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2024
Deferasirox Causes Leukaemia Cell Death through Nrf2-Induced Ferroptosis.

Wan-Yi Hsu, Li-Ting Wang, Pei-Chin Lin

|Apr 13, 2024
The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma.

Jeng-Shiun Du, Shih-Hsien Hsu, Shen-Nien Wang

|Feb 24, 2024
Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia/Lymphoma Using Single-Cell Sequencing Technologies.

Yu-Mei Liao, Shih-Hsien Hsu, Shyh-Shin Chiou

|Aug 26, 2023
Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies.

Pei-Chin Lin, Wan-Yi Hsu, Po-Yi Lee

|Jun 14, 2023
HCV Core Protein-ISX Axis Promotes Chronic Liver Disease Progression via Metabolic Remodeling and Immune Suppression.

Li-Ting Wang, Shen-Nien Wang, Shyh-Shin Chiou

Pageof 2